Meningiomas are the most common primary intracranial tumors. There are no effective
medical therapies for meningioma patients, and new treatments have been encumbered by …

Meningiomas are the most frequent primary intracranial tumors. Hence, they constitute a
major share of diagnostic specimens in neuropathology practice. The 2021 WHO …

Meningiomas are the most common primary central nervous system neoplasm. Despite
promising recent progress in elucidating the genomic landscape and underlying biology of …

Background Meningiomas, the most common primary intracranial tumors, can be separated
into 3 DNA methylation groups with distinct biological drivers, clinical outcomes, and …

Meningiomas comprise a histologically and clinically diverse set of tumors arising from the
meningothelial lining of the central nervous system. In the past decade, remarkable progress …

Surgery is the mainstay of treatment for meningioma, the most common primary intracranial
tumor, but improvements in meningioma risk stratification are needed and indications for …

Purpose Meningiomas are the most common primary intracranial tumor in older adults
(Ostrom et al. in Neuro Oncol 21 (Suppl 5): v1–v100, 2019). Treatment is largely driven by, in …

Meningiomas are the most common primary intracranial tumors of adults. For meningiomas
that progress or recur despite surgical resection and radiotherapy, additional treatment …

Background Advances in our understanding of the molecular biology of meningiomas have
led to significant gains in the ability to predict patient prognosis and tumor recurrence and to …

OBJECTIVE Meningioma is the most common primary intracranial neoplasm. Only 1%–3%
of meningiomas are malignant according to the 2016 WHO criteria (WHO grade III). High …